Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1Phase 3 1Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Polycystic Ovary Syndrome 6Squamous Cell Carcinoma of Head and Neck 2Obesity 2Endometrial Neoplasms 2Breast Neoplasms 2Urinary Bladder Neoplasms 1Triple Negative Breast Neoplasms 1Thoracic Neoplasms 1Prostatic Neoplasms 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Neuroendocrine Tumors 1Neoplasms 1Lymphoid Interstitial Pneumonia 1Laryngeal Diseases 1Insulin Resistance 1Inflammation 1Head and Neck Squamous Cell Cancer 1Head and Neck Neoplasms 1Glioblastoma 1Diabetes Mellitus 1Barrett Esophagus 1

Interventions

pembrolizumab 3atezolizumab 2trametinib 1sargramostim 1ruxolitinib 1reolysin 1poly(I).poly(c12,U) 1poly ICLC 1neratinib 1incomplete Freund's adjuvant 1glembatumumab vedotin 1epigallocatechin gallate 1entinostat 1dupilumab 1Zymosan 1Zinc 1Watchful Waiting 1Vaccines 1Uridine Monophosphate 1Trastuzumab 1Technetium Tc 99m Sestamibi 1Taxes 1Quercetin 1Positron-Emission Tomography 1Paclitaxel 1Neurofibromin 2 1Neoadjuvant Therapy 1Metformin 1Leukapheresis 1Letrozole 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Triple Negative Breast Neoplasms × Metformin × Clear all
NCT05680662 2023-01-11

The Study of Quadruple Therapy Quercetin, Zinc, Metformin, and EGCG as Adjuvant Therapy for Early, Metastatic Breast Cancer and Triple-negative Breast Cancer, a Novel Mechanism

Ministry of Health, Saudi Arabia

Phase EARLY_PHASE1 Unknown
200 enrolled
Breast

Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡